For the past several years, CROs and pharma companies have been forming strategic partnerships designed to improve quality and efficiency in the drug development process. But how strategic are they really? Where are the biggest gains being made? What are some of the pitfalls to avoid? Learn from senior thought leaders in the CRO and pharma industries who have broken new ground in the relationships between sponsors and CROs. These executives will share information on structure, governance, metrics and results.